Back

Safety and immunogenicity of anti-SARS CoV-2 conjugate vaccine SOBERANA 02 in a two-dose or three-dose heterologous scheme in adults: Phase IIb Clinical Trial

2022-01-05 infectious diseases Title + abstract only
View on medRxiv
Show abstract

BackgroundWe report results of immunogenicity, safety and reactogenicity of SOBERANA 02 in a two-dose or three-dose heterologous scheme in adults in a phase IIb clinical trial. MethodThis phase IIb trial was designed as parallel, multicentre, adaptive, double blind, randomized and placebo-controlled. Subjects (N=810) aged 19-80 years were randomized to receive two doses of the recombinant SARS CoV-2 receptor binding domain (RBD) conjugated to tetanus toxoid (SOBERANA 02) and a third dose of dim...

Predicted journal destinations

1
Vaccines
131 training papers
Top 0.1% 21.7%
2
Vaccine
140 training papers
Top 1% 11.6%
3
PLOS ONE
1737 training papers
Top 57% 10.7%
4
BMJ Open
553 training papers
Top 34% 4.9%
5
eClinicalMedicine
55 training papers
#1 4.9%
6
The Lancet Infectious Diseases
57 training papers
Top 0.5% 3.8%
7
Clinical Infectious Diseases
219 training papers
Top 15% 1.9%
8
Frontiers in Medicine
99 training papers
Top 8% 1.9%
9
Clinical Microbiology and Infection
54 training papers
Top 1% 1.9%
10
International Journal of Infectious Diseases
115 training papers
Top 8% 1.9%
11
Frontiers in Immunology
140 training papers
Top 6% 1.9%
12
New England Journal of Medicine
49 training papers
Top 1% 1.9%
13
Journal of Medical Virology
95 training papers
Top 7% 1.5%
14
Open Forum Infectious Diseases
124 training papers
Top 9% 1.5%
15
Scientific Reports
701 training papers
Top 89% 1.3%
16
The Journal of Infectious Diseases
137 training papers
Top 11% 1.3%
17
Journal of Infection
64 training papers
Top 6% 1.1%
18
JAMA Network Open
125 training papers
Top 24% 0.9%
19
BMC Infectious Diseases
110 training papers
Top 22% 0.9%
20
Human Vaccines & Immunotherapeutics
20 training papers
Top 0.5% 0.9%
21
BMJ
49 training papers
Top 5% 0.9%
22
Infectious Diseases and Therapy
18 training papers
Top 0.8% 0.7%
23
Eurosurveillance
77 training papers
Top 14% 0.7%
24
PLOS Neglected Tropical Diseases
166 training papers
Top 21% 0.7%
25
Heliyon
57 training papers
Top 15% 0.7%
26
PLOS Medicine
95 training papers
Top 24% 0.7%
27
Nature Communications
483 training papers
Top 61% 0.7%